My Medical Gateway News

Get back to your wicked self

    Why Britain Trusts European Healthcare

    As NHS delays continue to frustrate patients, a growing number of UK adults are looking across the Channel for faster, high-quality healthcare. Public surveys consistently show a positive perception of EU medical standards, with countries like Germany and France held in particularly high regard. This blog explores how shifting attitudes toward the EU and its healthcare systems are creating fertile ground for trusted cross-border treatment options – and why confidence in European care is rising.

    As the UK grapples with chronic delays in its public healthcare system, a shift in public perception is quietly taking place – one that lends strong support to the core mission of My Medical Gateway (MMG): connecting patients to trusted, high-quality healthcare across the European Union.

    The frustration at home is well documented. According to a 2023 joint report by the King’s Fund and the Nuffield Trust, only 20% of UK adults believe the NHS is well-run – the lowest level of satisfaction ever recorded. This erosion of confidence has prompted more Britons than ever before to explore alternatives. The Independent Healthcare Providers Network (IHPN)’s Going Private 2024 report found that 67% of UK adults would consider private healthcare, with 34% saying they expected to pay for treatment in the next 12 months. Notably, that number rises to 44% among 25- to 34-year-olds.

    CREDIT: Carmelo Garcia

    At the same time, a growing share of the UK population is taking out private medical insurance (PMI), with 11.8% of Britons now insured privately – a record high according to data published in 2024 by YouGov. The same period has also seen a doubling in self-funded surgeries across parts of the UK, such as Scotland, where one in three hip and knee replacements are now privately funded.

    These trends suggest a new willingness among UK patients to seek timely care, even if that means looking abroad. This openness is further supported by public attitudes toward the European Union and its healthcare systems.

    A 2024 YouGov survey found that Britons rank countries like Germany and France as more important than the UK itself when asked to assess the most influential countries in Europe. Fifty-nine percent ranked Germany as more important than the UK, and 46% said the same about France. This is more than just a geopolitical assessment – it reflects an implicit trust in how these countries operate, including their approach to healthcare.

    The perception that EU healthcare is better is gaining traction. A national UK survey conducted in 2024 found that 36% of respondents agreed – either strongly or somewhat – that many EU countries offer superior private healthcare to that available in the UK. This figure may not yet be a majority, but it is a clear and notable segment of the population, especially when layered atop existing dissatisfaction with the NHS.

    Broader European sentiment supports this direction. The 2023 Eurobarometer survey, Patient Safety and Quality of Care, highlighted that the majority of EU citizens feel positively about their own national healthcare systems. This external validation provides additional assurance to UK patients considering treatment in countries like Germany, France, the Netherlands, or Belgium.

    Demographics play a role as well. Reports from IHPN in 2025 show that younger Britons – particularly working professionals aged 25 to 44 – are driving growth in private diagnostics, such as scans and blood tests. Convenience, speed, and transparency are their guiding priorities. Many of these same individuals are digital natives who are comfortable navigating international options and using digital platforms to find better care.

    That mindset is bolstered by a parallel trend: digital health engagement is soaring. In 2024, YouGov found that 67% of UK adults use apps or devices to monitor their health. Meanwhile, market analysts like IMARC Group project that the UK digital health market will grow from $12.8 billion in 2024 to between $37 and $46 billion by 2030. Platforms that help patients compare, access, and book care – especially across borders – are positioned squarely in this growth curve.

    Culturally, the UK public remains more European than some headlines would suggest. A 2023 Ipsos survey found that 47% of Britons still regard Europe as the UK’s most important partner – far ahead of the United States (21%) or the Commonwealth (15%). Younger voters, in particular, maintain a favourable view of the EU and are more receptive to cooperation, travel, and service use across its member states.

    Taken together, these findings paint a clear picture. There is no longer a stigma attached to travelling to Europe for healthcare. On the contrary, there is a growing openness and even admiration for the efficiency, speed, and quality of care available across the Channel. Platforms that help UK patients navigate this space do not need to persuade people to trust European providers – they already do.

    For MMG, this validation matters. Our role is to facilitate access, provide quality assurance, and remove friction. The groundwork has been laid by years of shifting public attitudes. Today, what was once a niche idea – cross-border healthcare – is becoming a mainstream alternative.

    And that’s not just promising. It’s transformative.

    Posted in

    Leave a comment